COCRYSTAL PHARMA, INC. Disposal Group, Including Discontinued Operation, Revenue
COCRYSTAL PHARMA, INC. (COCP) reported Disposal Group, Including Discontinued Operation, Revenue of $8.43 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2014-03-31
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, revenue for the quarter ending 2013-12-31 was $8.03M, a 52.04% decline year-over-year.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, revenue for the quarter ending 2013-09-30 was $95.11K, a 40.41% decline year-over-year.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, revenue for the quarter ending 2012-12-31 was $16.74M.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, revenue for the quarter ending 2012-09-30 was $159.61K.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, revenue for fiscal 2013 was $8.43M, a 50.96% decline from fiscal 2012.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, revenue for fiscal 2012 was $17.19M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|
| 2013-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $8.12M derived: sum of 2 quarters · filed 2014-03-31 | $8.43M 10-K · filed 2014-03-31 | |
| 2013-09-30 | $95.11K 10-Q · filed 2013-11-18 | $402.86K 10-Q · filed 2013-11-18 | ||
| 2012-12-31 | $16.74M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $16.90M derived: sum of 2 quarters · filed 2014-03-31 | $17.19M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $159.61K 10-Q · filed 2013-11-18 | $454.96K 10-Q · filed 2013-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |